|03/16/17||ViewRay Reports Fourth Quarter and Full Year 2016 Financial Results|
|FDA 510(k) Clearance of MRIdian Linac in February Follows Strong 2016
Company Provides 2017 Financial Guidance
CLEVELAND, March 16, 2017 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) today announced financial results for the fourth quarter and full year ended December 31, 2016.
Fourth Quarter 2016 Highlights:
Total revenue of $16.1 million, up from $4.6 million in Q4 2015
Received 4 new orders for MRIdian Systems, totaling $24.3 million, up from 2 orders totaling $11.3 million in ... |
|03/14/17||ViewRay Announces Conference Call and Webcast of Fourth Quarter and Full Year 2016 Financial Results to be Held on March 16, 2017|
|CLEVELAND, March 14, 2017 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today details relating to the release of its fourth quarter and full year 2016 financial results, which will take place on Thursday, March 16, 2017 after market close.
ViewRay will hold a conference call on Thursday, March 16, 2017 at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results. The dial-in numbers are (844) 277-1426 for domestic callers and (336) 525-7129 for international callers. The conference ID numbe... |
|02/27/17||ViewRay Receives FDA 510(k) Clearance for MRIdian Linac|
|CLEVELAND, Feb. 27, 2017 /PRNewswire/ -- Announces Fourth Quarter and Full Year 2016 Financial Highlights, including Record Revenue and $133.2 million in Backlog
ViewRay, Inc. (Nasdaq: VRAY) announced today that the company received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the MRIdian Linac system, the company's next generation linear accelerator-based MRI-guided radiation therapy system.
"FDA clearance of the MRIdian Linac is a transformative milestone f... |
|02/22/17||ViewRay® to Participate in Upcoming Conferences|
|CLEVELAND, Feb. 22, 2017 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) announced today that Chris Raanes, Chief Executive Officer, and Ajay Bansal, Chief Financial Officer, are scheduled to participate in two upcoming investor conferences.
The first conference is the 2017 BTIG Medical Technology, Life Science and Diagnostic Tools Conference in Snowbird, Utah from February 28, 2017 through March 2, 2017. This conference will allow institutional investors to meet with the Company but does not i... |